BSE Live
Dec 31, 16:01Prev. Close
1387.65
Open Price
1373.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 31, 15:56Prev. Close
1386.20
Open Price
1386.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1418.90 (252)
| Cash Flow of Ipca Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 738.89 | 546.46 | 290.53 | 262.06 | 116.64 | |
| Net CashFlow From Operating Activities | 564.27 | 501.03 | 341.13 | 281.91 | 708.65 | |
| Net Cash Used In Investing Activities | -509.65 | -165.06 | -135.40 | -148.82 | -218.33 | |
| Net Cash Used From Financing Activities | -130.46 | -183.20 | -130.41 | -159.13 | -461.51 | |
| Foreign Exchange Gains / Losses | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -75.53 | 152.77 | 75.32 | -26.04 | 28.81 | |
| Cash And Cash Equivalents Begin of Year | 370.92 | 218.15 | 142.83 | 168.87 | 140.06 | |
| Cash And Cash Equivalents End Of Year | 295.39 | 370.92 | 218.15 | 142.83 | 168.87 |
05.12.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
17.11.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher